<DOC>
	<DOCNO>NCT02198846</DOCNO>
	<brief_summary>Insulin deficiency result progressive beta cell failure insulin resistance type 2 diabetes require exogenous insulin therapy , escape oral antihyperglycemic agent . Previous data suggest continuous subcutaneous insulin infusion ( CSII ) efficacy glucose control also restore beta cell failure . The investigator plan compare efficacy/safety beta cell function insulin pump treatment intensification conventional treatment patient uncontrolled type 2 diabetes .</brief_summary>
	<brief_title>A Study Compare Insulin Pump With Conventional Treatment Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 2 diabetes age : 18 ~ 85 yrs HbA1c : &gt; 7.5 % change antidiabetic medication within 3 month systemic corticosteroid administer within previous 6 month pregnancy severe liver renal disease , heart failure History cancer within 5 year Thyroid disease Antiobesity drug slimming product within previous 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>